Vyne Therapeutics Inc. (VYNE) at a glance

Vyne Therapeutics Inc. (VYNE) is a micro-cap Healthcare company. It trades at $39.5, with a P/E of 0.7, a 0% profit margin and revenue decline of 57.4%. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Value (99/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$39.50

Market cap

$26.4M

P/E ratio

0.7

Dividend yield

None

Beta

2.01

52-week range

$0.28 to $46.95